Opioid poorly-responsive cancer pain. Part 3. Clinical strategies lo improve opioid responsiveness

Citation
S. Mercadante et Rk. Portenoy, Opioid poorly-responsive cancer pain. Part 3. Clinical strategies lo improve opioid responsiveness, J PAIN SYMP, 21(4), 2001, pp. 338-354
Citations number
188
Categorie Soggetti
General & Internal Medicine","Neurosciences & Behavoir
Journal title
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
ISSN journal
08853924 → ACNP
Volume
21
Issue
4
Year of publication
2001
Pages
338 - 354
Database
ISI
SICI code
0885-3924(200104)21:4<338:OPCPP3>2.0.ZU;2-I
Abstract
Some pain syndromes may be difficult to treat due to a poor response to opi oids. This situation demands a range of alternative measures, including the use of adjuvant drugs with independent effects, such as antidepressants, s odium channel-blocking agents, steroids and anti-inflammatory drugs (NSAIDs ); drugs that reduce opioid side effects; and drugs that enhance analgesia produced by opioids, such as N-methyl-D-aspartate (NMDA) antagonists, calci um channel antagonists, and clonidine. Other approaches, including opioid t rials, neural blockade when necessary and psychological interventions, also may be useful. (C) U.S. Cancer Pain Relief Committee, 2001.